{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Haemophilus+Infections&page=2", "query": { "condition": "Haemophilus Infections", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Haemophilus+Infections&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T12:01:43.650Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00509106", "title": "Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil for Injection", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 622, "start_date": "2007-07", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00509106" }, { "nct_id": "NCT01732198", "title": "A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infectious Disease" ], "interventions": [ { "name": "NU300", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Prevnar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Nuron Biotech Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 220, "start_date": "2013-03", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2013-09-23", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 2, "location_summary": "Oakland, California • Bardstown, Kentucky", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01732198" }, { "nct_id": "NCT00034086", "title": "Study of Anti-HIV Therapy Intensification", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Lopinavir/Ritonavir", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Tenofovir disoproxil fumarate", "type": "DRUG" }, { "name": "Pneumococcal Vaccine, Polyvalent (23-valent)", "type": "BIOLOGICAL" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Stavudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" }, { "name": "Didanosine", "type": "DRUG" }, { "name": "Lyme Disease Vaccine Recombinant OspA", "type": "BIOLOGICAL" }, { "name": "Haemophilus B Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 22, "start_date": null, "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 3, "location_summary": "Aurora, Colorado • Chicago, Illinois • Cleveland, Ohio", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00034086" }, { "nct_id": "NCT00483574", "title": "Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" }, { "name": "Measles-mumps-rubella-varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Routine paediatric vaccine - Pneumococcal conjugate (PCV)", "type": "BIOLOGICAL" }, { "name": "Routine paediatric vaccine - Hepatitis A", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "9 Months to 12 Months" }, "enrollment_count": 1378, "start_date": "2007-05", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-05-16", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 78, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Pinson, Alabama + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Pinson", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00483574" }, { "nct_id": "NCT00621504", "title": "Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil for Injection", "type": "DRUG" }, { "name": "IV Ceftriaxone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Clarithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 606, "start_date": "2008-01", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 12, "location_summary": "Los Angeles, California • Pasadena, California • Sacramento, California + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621504" }, { "nct_id": "NCT00345579", "title": "Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b", "Neisseria Meningitidis" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pediarix/Infanrix Penta", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4432, "start_date": "2006-09", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00345579" }, { "nct_id": "NCT02294487", "title": "Study of the Immune Response After Vaccination in Multiple Myeloma Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Myeloma", "Myeloma, Multiple", "Myeloma-Multiple" ], "interventions": [], "intervention_types": [], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 19, "start_date": "2014-12-30", "completion_date": "2017-08-10", "has_results": false, "last_update_posted_date": "2024-10-03", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02294487" }, { "nct_id": "NCT01978093", "title": "Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neisseria Meningitidis", "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "Hib-MenCY-TT (MenHibrix®)", "type": "BIOLOGICAL" }, { "name": "Pediarix®", "type": "BIOLOGICAL" }, { "name": "Rotarix®", "type": "BIOLOGICAL" }, { "name": "Prevnar 13®", "type": "BIOLOGICAL" }, { "name": "PedvaxHIB®", "type": "BIOLOGICAL" }, { "name": "Havrix®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 600, "start_date": "2014-02-01", "completion_date": "2016-03-18", "has_results": true, "last_update_posted_date": "2018-09-14", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01978093" }, { "nct_id": "NCT00662870", "title": "Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Tetanus", "Whooping Cough", "Polio", "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)", "type": "BIOLOGICAL" }, { "name": "Pentacel: DTaP-IPV/Hib", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "84 Days", "sex": "ALL", "summary": "42 Days to 84 Days" }, "enrollment_count": 1941, "start_date": "2001-05", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2012-01-31", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 26, "location_summary": "Fayetteville, AR 72703, Arkansas • Jonesboro, AR 72401, Arkansas • Little Rock, AR 72211, Arkansas + 23 more", "locations": [ { "city": "Fayetteville, AR 72703", "state": "Arkansas" }, { "city": "Jonesboro, AR 72401", "state": "Arkansas" }, { "city": "Little Rock, AR 72211", "state": "Arkansas" }, { "city": "Fountain Valley, CA 92708", "state": "California" }, { "city": "Englewood, CO 80112", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00662870" }, { "nct_id": "NCT00422292", "title": "Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, Rubella and Varicella", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "9 Months to 12 Months" }, "enrollment_count": 1664, "start_date": "2006-12", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-06-10T12:01:43.650Z", "location_count": 87, "location_summary": "Tuscaloosa, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 74 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Atascadero", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00422292" } ] }